ALT FLARES DURING TREATMENT WITH PEGINTERFERON LAMBDA OR PEGINTERFERON alfa IN PATIENTS WITH HBeAg-POSITIVE CHRONIC HEPATITIS B INFECTION (CHB)

739 ALT FLARES DURING TREATMENT WITH PEGINTERFERON LAMBDA OR PEGINTERFERON alfa IN PATIENTS WITH HBeAg-POSITIVE CHRONIC HEPATITIS B INFECTION (CHB) H.L. Chan, S.H. Ahn, T.-T. Chang, C.-Y. Peng, D. Wong, C. Coffin, S.G. Lim, P.-J. Chen, H.L. Janssen, P. Marcellin, L. Serfaty, S. Zeuzem, W. Hu, L. Critelli, M. Wind-Rotolo, S. Srinivasan, J.C. Lopez-Talavera, E. Cooney. Chinese University of Hong Kong, Hong Kong SAR, China; Yonsei University Severance Hospital, Seoul, Republic of Korea; National Chen Kung University Hospital, Tainan, China Medical University Hospital, Taichung, Taiwan R.O.C.; Toronto Western Hospital University Health Network, Toronto, ON, Liver Unit, Division of Gastroenterology and Hepatology, University of Calgary, Calgary, AB, Canada; National University Hospital, Singapore, Singapore, National Taiwan University Hospital, Taipei, Taiwan R.O.C.; Erasmus Medical Center, Rotterdam, The Netherlands; Hopital Beaujon, Clichy, Hopital Saint Antoine, Paris, France; Johann Wolfgang Goethe University, Frankfurt, Germany; Bristol-Myers Squibb, Wallingford, CT, Bristol-Myers Squibb, Princeton, NJ, USA E-mail: hlychan@cuhk.edu.hk